Actinium Pharmaceuticals Inc (ATNM)
9.80
-0.05
(-0.51%)
USD |
NYAM |
May 17, 16:00
9.75
-0.05
(-0.51%)
After-Hours: 20:00
Actinium Pharmaceuticals Price to Book Value: 6.655 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 17, 2024 | 6.655 |
May 16, 2024 | 6.689 |
May 15, 2024 | 6.608 |
May 14, 2024 | 6.716 |
May 13, 2024 | 6.017 |
May 10, 2024 | 5.929 |
May 09, 2024 | 6.044 |
May 08, 2024 | 5.915 |
May 07, 2024 | 5.983 |
May 06, 2024 | 6.003 |
May 03, 2024 | 6.085 |
May 02, 2024 | 5.942 |
May 01, 2024 | 5.283 |
April 30, 2024 | 5.229 |
April 29, 2024 | 5.012 |
April 26, 2024 | 4.666 |
April 25, 2024 | 4.397 |
April 24, 2024 | 4.732 |
April 23, 2024 | 4.665 |
April 22, 2024 | 4.806 |
April 19, 2024 | 4.591 |
April 18, 2024 | 4.471 |
April 17, 2024 | 4.860 |
April 16, 2024 | 5.188 |
April 15, 2024 | 5.657 |
Date | Value |
---|---|
April 12, 2024 | 6.032 |
April 11, 2024 | 6.093 |
April 10, 2024 | 6.026 |
April 09, 2024 | 6.019 |
April 08, 2024 | 6.120 |
April 05, 2024 | 6.394 |
April 04, 2024 | 6.120 |
April 03, 2024 | 5.925 |
April 02, 2024 | 5.764 |
April 01, 2024 | 5.738 |
March 28, 2024 | 6.327 |
March 27, 2024 | 6.416 |
March 26, 2024 | 6.197 |
March 25, 2024 | 6.617 |
March 22, 2024 | 7.021 |
March 21, 2024 | 6.953 |
March 20, 2024 | 6.564 |
March 19, 2024 | 6.266 |
March 18, 2024 | 4.991 |
March 15, 2024 | 5.152 |
March 14, 2024 | 4.785 |
March 13, 2024 | 5.113 |
March 12, 2024 | 5.029 |
March 11, 2024 | 5.281 |
March 08, 2024 | 5.838 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.376
Minimum
Mar 14 2022
57.57
Maximum
Jun 22 2020
4.394
Average
3.148
Median
Aug 18 2023
Price to Book Value Benchmarks
Perspective Therapeutics Inc | 4.333 |
Eli Lilly and Co | 57.12 |
Cellectar Biosciences Inc | 13.02 |
Outlook Therapeutics Inc | -- |
Bristol-Myers Squibb Co | 5.413 |
Price to Book Value Related Metrics
PEG Ratio | -0.1595 |
Price | 9.80 |
Earnings Yield | -17.45% |
Market Cap | 291.88M |
PEGY Ratio | -0.1595 |